Press Releases
 
Liver Fibrosis Drugs Market Detailed Study Analysis with Forecast by 2025

, 16 March 2019 -- Liver fibrosis is the most common liver condition. It is the imbalance of decomposition and synthesis of the extra cellular matrix (ECM) and collagens caused by necrosis and liver cell inflammation. Cellular components primarily are fibroblastic cells, hepatic stellate cells (HSC), and mononuclear macrophages cells. Extra cellular matrix (ECM) is composed of glycoproteins, collagen, and protein-polysaccharides. Fibrosis is a process when connective tissue starts to proliferate in the portal area. In a normal liver, 5.5 mg to 6.5 mg of collagen can be found in every gram of liver tissue. Cirrhotic liver contains over 8.0 mg of collagen in every gram of liver tissue. It can also be higher than 20 mg. Liver fibrosis can be categorized into viral hepatitis fibrosis, parasitic infection fibrosis, alcoholic fibrosis, biliary fibrosis, intoxication fibrosis, cardiogenic fibrosis, and metabolic fibrosis. Immunologically, liver fibrosis can be categorized into passive fibrosis and active fibrosis. Viral hepatitis fibrosis is the most common form of liver fibrosis and is usually caused by chronic hepatitis C, B, and D. According to PubMed and scientific journal research, over 500 million people are affected by hepatitis B and C virus. Infected people develop chronic hepatitis, which leads to fibrosis. Liver fibrosis can cause major complications, including liver failure, portal hypertension, and liver cancer. The risk of liver cancer is greatly increased once fibrosis develops. Liver cancer is among the top ten causes of death globally. High alcohol consumption, fatty liver (steatosis), and insulin resistance increase the risk of liver fibrosis.

Read Report Overview:
https://www.transparencymarketresearch.com/liver-fibrosis-drugs-market.html

The global liver fibrosis drugs market is expanding significantly due to increase in prevalence of the disease. Long term medication also increases the incidence of liver fibrosis. Rise in funding by government and private sector for the treatment of liver fibrosis in terms of reimbursement is projected to drive the market during the forecast period. Low rate of voluntary screening for the disease is a major restraint of the market.

The global liver fibrosis drugs market can be segmented based on drug class, distribution channel, and region. In terms of drug class, the market can be categorized into interferon (IFN) therapy, nucleoside analogue, maloti lipid, and others.

Based on distribution channel, the global liver fibrosis drugs market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. In terms of revenue, the hospital pharmacies segment is projected to hold a significant share of the liver fibrosis drugs market in 2016.

In terms of region, the global liver fibrosis drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for liver fibrosis drugs. In terms of revenue, the U.S. holds a major share of the liver fibrosis drugs market in North America. The market in Europe is expanding rapidly due to increase in the patient population in the region, especially in the U.K. and Germany. The market in Asia Pacific and Latin America is projected to expand significantly in the near future. Developing economies such as China and India are anticipated to contribute to the growth of the market in Asia Pacific between 2017 and 2025, due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and increase in awareness among people in these countries.

Request Brochure of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37853

Key players operating in the global liver fibrosis drugs market are Bristol-Myers Squibb Company, Gilead Sciences, Inc., Celgene Corporation, Pfizer, Inc., FibroGen, Inc., Pharmaxis Limited, Dicerna Pharmaceuticals, Inc., LG Life Science Ltd., and Dynavax Technologies Corporation.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/



# # #


Submitted by hawer on Saturday, 16 March 2019 at 2:35 AM
Category: Health Care & Medical
 
Related News

Hormonal Contraceptive Market is Projected to Soar at a Value CAGR of 5% from 2018 to 2026
Tuesday, 19 Mar 2019

Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market: Overview with Detailed An
Tuesday, 19 Mar 2019

Oxytocic Pharmaceuticals Market: Overview with Detailed Analysis, Competitive landscape Forecast to
Tuesday, 19 Mar 2019

Video Telemedicine Market to Report a CAGR of 16.5% Between 2014 and 2020
Tuesday, 19 Mar 2019

Healthcare Business Intelligence platform Market to Attain a Value of US$ 3.9 Bn by 2023
Tuesday, 19 Mar 2019

Related Events

The 29th International Pediatric Association (IPA) Congress 2019
Sunday, 17 Mar 2019

10th Proactive GCP Compliance
Monday, 18 Mar 2019

World Pharma Pricing and Market Access Congress 2019
Tuesday, 19 Mar 2019

Innate Killer Summit 2019
Tuesday, 19 Mar 2019

Middle East Pharmaceutical Cold Chain Conference
Tuesday, 19 Mar 2019

Latest News

The Best Credit Card Processing Services From Leaders Merchant Services
Tuesday, 19 Mar 2019

Treatments for Epilepsy with Stem Cell Therapy
Tuesday, 19 Mar 2019

Saudi Arabia Electric Motor Market (2017–2023)
Tuesday, 19 Mar 2019

Heavy-Duty Mats – Rubber Flooring Experts
Tuesday, 19 Mar 2019

Hormonal Contraceptive Market is Projected to Soar at a Value CAGR of 5% from 2018 to 2026
Tuesday, 19 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 19 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • The 29th International Pediatric Association (IPA) Congress 2019
  • Applied Data Analytics Upstream 2019
  • LEAP HR: Retail Conference 2019, Austin
  • 10th Proactive GCP Compliance
  • Palo Alto Networks: NERCOMP Annual Conference

  • Latest Jobs
    Sorry, there are currently no entries posted here.